UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 1, 2012
|
INSMED INCORPORATED
|
|
(Exact Name of Registrant as Specified in Its Charter)
|
|
Virginia
|
|
(State or Other Jurisdiction of Incorporation)
|
|
0-30739
|
54-1972729
|
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
9 Deer Park Drive, Suite C,
Monmouth Junction, New Jersey
|
08852
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
(732) 997-4600
|
|
(Registrant’s Telephone Number, Including Area Code)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
£
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
£
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
£
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
£
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
During the first quarter of 2012, Insmed Incorporated (the “Company”) adopted an accounting standard which eliminated the option to present the components of other comprehensive income as part of the statement of changes in stockholders’ equity, which was the presentation used in the Company’s 2011 Annual Report on Form 10-K. The adopted accounting standard requires the presentation of the components of net income, other comprehensive income and total comprehensive income in either one continuous statement or two separate consecutive statements. The components of other comprehensive (loss) income and total comprehensive income (loss) for the years ended December 31, 2011, 2010 and 2009 are presented below (in millions).
|
Year Ended December 31,
|
||||||||||||
|
2011
|
2010
|
2009
|
||||||||||
|
Net (loss) income
|
$ | (59,664 | ) | $ | (6,434 | ) | $ | 118,350 | ||||
|
Unrealized (loss) gain on short-term investments
|
(543 | ) | 548 | 445 | ||||||||
|
Total comprehensive (loss) income
|
$ | (60,207 | ) | $ | (5,886 | ) | $ | 118,795 | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Insmed Incorporated
|
|
|
Date: August 1, 2012
|
||
| By: |
/s/ Timothy Whitten
|
|
| Name: |
Timothy Whitten
|
|
|
Title:
|
President and Chief Executive Officer
|
|